Antheia Raises $56 Million in Series C Financing to Fuel Global Commercialization Strategy
New funding will support the company’s rapid growth trajectory and efforts to transform pharmaceutical supply chains with its advanced biomanufacturing platform.
- 03 06 2025
- |